Home
News & Events > Press Releases

Press Releases

 

 

 

 

Top

Press Releases 2010

PDF
02 Feb 2010
Cellectis to Present at BIO CEO and Investor Conference
PDF
27 Jan 2010
Cellectis receives the 2009 INPI National Innovation Award
PDF
21 Jan 2010
Cellectis’ new approach to meganuclease engineering published in an international scientific journal
PDF
19 Jan 2010
Cellectis and the French National Institute for Agricultural Research (INRA) sign cooperation agreement
PDF
15 Jan 2010
Contrat de liquidité Natixis : Bilan au 31 décembre 2009
PDF
13 Jan 2010
Cellectis Recaps 2009 Accomplishments: Key Business Objectives for the Year Were Achieved
PDF
13 Jan 2010
Invitation Cellectis - Inra : Un accord de coopération entre la recherche publique et un leader mondial de l'ingenierie des génomes
PDF
12 Jan 2010
Cellectis grants Bayer HealthCare license to use homologous recombination patents
PDF
11 Jan 2010
Cellectis to attend BioPartnering North America 2010 in Vancouver, Canada

Top

Press Releases 2009

PDF
17 Dec 2009
Cellectis bioresearch launches first kit from cGPS® Custom line for use in human cell lines.
PDF
10 Dec 2009
Cellectis bioresearch and tebu-bio join forces for the distribution of cGPS® and cGPS® Custom targeted integration kits.
PDF
07 Dec 2009
Cellectis bioresearch announces the launch of its first cGPS® kit for use in gene function studies
PDF
03 Dec 2009
Vente d’actions Cellectis par ses dirigeants.
PDF
01 Dec 2009
Cellectis receives the INPI Ile-de-France Innovation award
PDF
18 Nov 2009
Cellectis European patent EP 1 485 475 upheld against Precision BioSciences at European Patent Office
PDF
18 Nov 2009
Cellectis rectifies Genoway’s statements
PDF
12 Nov 2009
Verdict confirms Cellectis’ fight to protect its intellectual property
PDF
04 Nov 2009
Cellectis bioresearch launches cGPS® CHO-S CEMAX® - an efficient protein production kit
PDF
12 Oct 2009
Cellectis Acquires Vectocell® Technology to Accelerate Therapeutic Development Programs
PDF
08 Oct 2009
A New Model for Studying Meganuclease-Based Therapeutic Approaches Featured in International, Peer-Reviewed Journal Blood
PDF
06 Oct 2009
Cellectis publishes its financial statement for the first half of 2009: continued growth and on track for sustained profitability by 2012
PDF
05 Oct 2009
Latest Launch in Cellectis bioresearch’s cGPS® Product Family Enables Screening Against Difficult-to-Express Drug Targets
PDF
30 Sep 2009
Cellectis launches Ectycell subsidiary dedicated to Stem Cells Applications
PDF
28 Sep 2009
Cellectis reaches 40th meganuclease milestone.
PDF
21 Sep 2009
Cellectis S.A. appoints Dr Sylvie Delassus as Senior Vice President Communications, member of the Executive Committee
PDF
09 Sep 2009
Cellectis S.A. will take part in the MidCap Event on September 21st and 22nd in Palais Brongniart, Paris
PDF
01 Sep 2009
MONSANTO LICENSES USE OF CELLECTIS’ INNOVATIVE GENOME MODIFICATION TECHNOLOGY
PDF
07 Jul 2009
Cellectis announces the publication of a paper entitled “Efficient targeting of a SCID gene by an engineered single chain homing endonuclease” in Nucleic Acids Research
PDF
16 Jun 2009
Cellectis bioresearch launches cGPS® Custom - the world's first line of kits for targeted gene integration in native cell lines
PDF
10 Jun 2009
CELLECTIS SA CLARIFIES COMPETITOR’S COMMENTS ON PRELIMINARY U.S. PATENT OFFICE ACTION
PDF
10 Jun 2009
Cellectis bioresearch adds Celonic’s High-Producer CEMAX® Cell Line to Portfolio
PDF
08 Jun 2009
Cellectis announces coverage by Natixis Securities
PDF
02 Jun 2009
Limagrain takes a commercial license to Cellectis' I-SceI meganuclease technology for use in plants.
PDF
05 May 2009
Laboratoires Servier signs licensing agreement with Cellectis for use of π10® modified cell lines in drug screening
PDF
27 Mar 2009
Full-year results for 2008 in line with Cellectis’ development strategy:
PDF
26 Mar 2009
Conference call invitation In connection with the 2008 results of the biotech company Cellectis
PDF
09 Feb 2009
Two key nominations for Cellectis: Professor José Alain Sahel joins the Scientific Advisory Board and Professor Roger J. Hajjar joins the Board of Directors
PDF
30 Jan 2009
Cellectis bioresearch appoints Luc Selig as Vice President Sales & Marketing
PDF
05 Jan 2009
Cellectis terminates Genoway's License under its Homologous Recombination technology.

Top

Press Releases 2008

PDF
01 Dec 2008
Cellectis BioResearch, announces the market launch of a first revolutionary research kit
PDF
20 Nov 2008
Cellectis SA announces the appointment of Dr. Dirk Pollet as Chief Business Officer.
PDF
05 Nov 2008
Publication in NATURE Magazine of an article describing the design of a Therapeutic Meganuclease to treat a severe skin inborn disease by the CNIO, the CRG and Cellectis.
PDF
23 Oct 2008
Cellectis and Genomic Vision receive 10 million euros of funding from Oséo-ISI to develop a revolutionary treatment for HIV and herpes.
PDF
25 Sep 2008
Cellectis S.A. announces its financial results for the 1st half of 2008: Net income of €1.3m with 100% increase in expenses and 200% in sales.
PDF
16 Sep 2008
The French Muscular Dystrophy Association (AFM) and Cellectis launch a genome surgery program for curing genetic diseases.
PDF
03 Jul 2008
Cellectis and Regeneron sign an agreement over the use of homologous recombination technology.
PDF
30 Jun 2008
Biotechnology company Cellectis S.A. announces the inception of two subsidiaries: Cellectis BioResearch to develop and market research kits and Cellectis Genome Surgery to develop therapeutics.
PDF
09 May 2008
Cellectis sues Shionogi for infringement of its Patents concerning Homologous Recombination Technology.
PDF
22 Apr 2008
Cellectis announces the publication of a paper entitled "Computer design of obligate heterodimer meganucleases allows efficient cutting of custom DNA sequences" in Nucleic Acids Research.
PDF
10 Apr 2008
Cellectis S.A. announces participation in the SmallCap Event On April 21st and 22nd in Paris, 'hotel Hilton Suffren' in Paris.
PDF
08 Apr 2008
Cellectis S.A. announces its financial results for 2007: operating expenses grow (+27%) in parallel with sales (+22%).
PDF
13 Mar 2008
Cellectis sues Precision BioSciences for Infringement of its patents concerning Meganuclease technology.
PDF
27 Feb 2008
The biotechnology company Cellectis S.A. announces a turnover of around €425k for the fourth quarter of 2007.
PDF
21 Feb 2008
Cellectis announces positive outcome in IP battle.
PDF
16 Jan 2008
Cellectis S.A. Annonce son Calendrier Financier et de Relations Investisseurs pour 2008, ainsi que la mise à disposition d'informations dédiées sur son site web. Jan 16 2008 Cellectis S.A. Annonce son Calendrier Financier et de Relations Investisseurs pour 2008, ainsi que la mise à disposition d'informations dédiées sur son site web.

Top

Press Releases 2007

10 Dec 2007
Two significant nominations for Cellectis: Professor Alain Fischer joins the Scientific Advisory Board and Alain Godard joins the Board of Directors.
06 Dec 2007
Cellectis announces the publication of a key article in the Journal of Biological Chemistry.
15 Nov 2007
Cellectis announces delivery of a meganuclease targeting the RAG1 gene (responsible for a severe immunodeficiency) to Professor Luigi Notarangelo's research group at the Children's Hospital Boston (USA).
13 Nov 2007
La société de biotechnologie Cellectis S.A. annonce un chiffre d'affaires de 161k€ au troisième trimestre 2007.
15 Oct 2007
Cellectis grants TransGenic a non-exclusive license to its homologous recombination technology.
08 Oct 2007
Laboratoires Servier and Cellectis sign an agreement in the field of cell engineering.
25 Sep 2007
Cellectis' Financials for First Semester 2007.
15 Sep 2007
Cellectis announces the presentation of results demonstrating the correction of an XP mutation in a patient's cell line by homologous gene targeting at the first French-German meeting on DNA repair, damage signaling and carcinogenesis in Toulouse.
14 Sep 2007
Cellectis annonce la livraison d'une méganucléase ciblant le gène IL2RG responsable d'une immunodéficience sévère liée au chromosome X (enfants-bulles X-SCID) à l'Equipe du Professeur Alain Fisher, Hôpital Necker (INSERM U768).
11 Sep 2007
Cellectis S.A. announces participation in the MidCap Event.
26 Jul 2007
Cellectis announces the delivery of two meganucleases targeting the p53 gene in the framework of the NETSENSOR European program.
26 Jun 2007
Cellectis announces the publication of a paper entitled " Engineered I-CreI Derivatives Cleaving Sequences from the Human XPC Gene can Induce Highly Efficient Gene Correction in Mammalian Cells" in the Journal of Molecular Biology.
18 Jun 2007
Election of Professor Richard C. Mulligan to Cellectis' Board of Directors.
11 Jun 2007
Cellectis S.A. wins a patent battle in the field of targeted recombination and gene correction.
04 Jun 2007
The Institut Pasteur and Cellectis announce the grant of a key European patent covering the use of homologous recombination in eukaryotes.
30 May 2007
Cellectis S.A.'s first combined Annual and Special Shareholders General Meeting, May 30, 2007.
28 May 2007
Cellectis reaches key milestone in collaboration with Bayer Cropscience on uses of Meganuclease technology in plants.
23 May 2007
Cellectis will begin continuous trading on Alternext of Euronext Paris on May 24th 2007.
22 May 2007
INFORMATION CONCERNING CELLECTIS S.A.'S FIRST COMBINED ANNUAL AND SPECIAL SHAREHOLDERS GENERAL MEETING - Meeting is due to be held on May 30 2007.
10 May 2007
Cellectis announces the publication of a paper entitled "The C-terminal loop of the homing endonuclease I-CreI is essential for site recognition, DNA binding and cleavage" in the journal Nucleic Acids Research.
04 May 2007
Cellectis grants GlaxoSmithKline a non-exclusive sub-license for its homologous recombination technology.
03 May 2007
Cellectis S.A. announces its attendance at two high-profile conventions: The BIO International Convention, Boston, May 6th-9th 2007 and BioEquity Europe , Glasgow, May 21st-22nd 2007.
17 Apr 2007
Cellectis S.A. announces its financial results for the fiscal year ending Dec 31 2006.
12 Apr 2007
April the 13rd, 2007, Cellectis will host for the second year, the next GDR 2825 workshop on "Novel approaches on Directed Protein Evolution", at his Romainville headquarters (Paris region).
03 Apr 2007
Celonic and Cellectis announce a commercial license agreement following key milestone in meganuclease-mediated cell line engineering for biomanufacturing.
02 Apr 2007
Cellectis S.A. Announces its 2007 Financial and Investor Relations Calendar.
30 Mar 2007
Cellectis S.A., the Alternext-listed innovative company, receives a €1.4 million grant from OSEO Innovation (ANVAR).
19 Mar 2007
Cellectis S.A. announces the publication of a Current Gene Therapy article on Meganucleases and its Perspectives for Gene Therapy.
05 Mar 2007
Cellectis S.A. announces the full exercise of the greenshoe in the context of its initial public offering on the Alternext market of Euronext Paris.
06 Feb 2007
Cellectis S.A. announces the success of its initial public offering on the Alternext market of Euronext Paris.
23 Jan 2007
Cellectis S.A. announces the launch of its initial public offering on the Alternext market of Euronext Paris.
08 Jan 2007
Cellectis S.A. announces the publication of a Journal Nucleic Acids Research (NAR) article on artificial homing endonuclease.

Top

Press Releases 2006

26 Dec 2006
Cellectis S.A. announces the registration of its Document de Base with the AMF in the context of the Company's contemplated initial public offering on the Alternext market of Euronext Paris.
18 Oct 2006
Cellectis is distinguished with the Ernst & Young Entrepreneur Award as the "High Prospective Company" of Year 2006.
02 Oct 2006
Cellectis Appoints Marc Le Bozec As Chief Financial Officer.
11 Jul 2006
Cellectis has been granted a worldwide License to Lexicon Genetics' Isogenic DNA Technology.
30 Jun 2006
Cellectis and Bayer CropScience enter into a collaboration to use Meganuclease technology in plants.
23 May 2006
June the 2nd 2006, Cellectis will host the next GDR 2825 workshop on "Novel approaches on Directed Protein Evolution", at his Romainville headquarters (Paris region).
19 Apr 2006
Cellectis and Genentech have entered into a worldwide, non-exclusive license agreement under patent families relating to a process for the specific replacement or insertion of a gene in the receiver genome by homologous recombination for in vitro and in vi
14 Mar 2006
Cellectis announces publication of data demonstrating ability of meganucleases to induce efficient in toto recombination in mouse liver.
21 Feb 2006
Cellectis SA and Celonic GmbH enter in collaboration and license agreement for mammalian cell lines engineering for bio-production purposes.
03 Jan 2006
Cellectis and BASF Plant Science sign a License under the Meganuclease technology for marker genes excision in crops.

Top

Press Releases 2005

20 Dec 2005
Cellectis S.A. Announces an Agreement with Shire Pharmaceuticals in the field of gene activated proteins
13 Dec 2005
Cellectis signs Worldwide Non-Exclusive License agreement with AstraZeneca covering the use of the Homologous Recombination
23 Nov 2005
Cellectis SA reports method for the selection of novel engineered meganucleases in Nucleic Acids Research
21 Nov 2005
Cellectis SA reports the Engineering of large numbers of Novel Highly Specific Homing Endonucleases, in the Journal of Molecular Biology
03 Nov 2005
Cellectis distinguished with the Research Company of Year 2005 Award.
18 Oct 2005
Cellectis is awarded the "Best Pharma Partnering" Trophy 2005 by Pharma Industry Association
21 Sep 2005
Cellectis announces Research Collaboration and License Agreement with Biogen Idec to engineer a novel customized Meganuclease Recombination System.
31 Jul 2005
Cellectis SA reports in Biotechniques on factors affecting meganuclease-induced recombination of direct repeats in mammalian cells.
12 Jul 2005
Cellectis S.A. and Ozgene Pty Ltd. Enter into a License Agreement.
29 Jun 2005
Cellectis S.A. Announces a License Agreement with Xenogen Biosciences Corporation.
14 Jun 2005
Cellectis S.A. wins patent battle in the field of targeted recombination and gene correction.
31 May 2005
Cellectis S.A. and CellianceTM, a Serologicals Company, enter in collaboration for mammalian cell lines engineering for production purposes.

Top

Press Releases 2004

16 Dec 2004
Cellectis is distinguished with the Entrepreneur of the Year 2004 award.
23 Nov 2004
Bankinvest is awarded the Investor's Trophy at BIORIF 2004 for its investment in Cellectis SA.
22 Nov 2004
Cellectis S.A. Grants Lexicon Genetics a Technology Sublicense.
26 May 2004
Cellectis S.A., with the intermediation of Ascenion GmbH, has entered into a multi-tiered license agreement with four German Academic Research Centers, for its patents family covering certain uses of Homologous Recombination.
13 May 2004
Cellectis S.A. and Murinus GmbH enter into a License agreement for the use of the Homologous Recombination in generating mouse models.
01 Mar 2004
Cellectis SA has moved to a new facility at Aventis' Biocitech Park, in Romainville, Paris area.
25 Feb 2004
Cellectis SA extends its Technology Agreement with BASF Plant Science GmbH for marker genes excision in crops
11 Feb 2004
Cellectis announces a License agreement with Regeneron Pharmaceuticals relating to the use of the Homologous Recombination in Velocigene© Platform.
06 Jan 2004
Cellectis SA and Diversa enter into a License Agreement for microorganisms improvement.

Top

Press Releases 2003

18 Nov 2003
Cellectis SA and Fermentas enter into a License Agreement.
03 Jun 2003
Cellectis SA announces publication in Nucleic Acids Research of the generation of a novel hybrid meganuclease.
19 May 2003
Cellectis SA and BASF Plant Science GmbH enter into Technology Agreement
09 Apr 2003
Cellectis and Limagrain Group announce an agreement
26 Mar 2003
Two major patents on homologous recombination issued in the United States.
16 Mar 2003
Cellectis grants Nucleis a non-exclusive commercial license under the patent family covering the use of the homologous recombination in mice.
06 Mar 2003
Pioneer to Assess Cellectis Technology for Use in Trait Development.
01 Mar 2003
Cellectis grants Deltagen a Worldwide Non-Exclusive License under the Patent Family covering the use of the Homologous Recombination in Rodents.

Top

Press Releases 2002

19 Sep 2002
Cellectis and Artemis Pharmaceuticals sign a license agreement.
25 Jun 2002
Cellectis SA announces the completion of its second financing round.

Top

Press Releases 2001

23 Oct 2001
Cellectis and genOway sign a license agreement
30 Aug 2001
Cellectis and Zentaris sign a license agreement
15 Mar 2001
Cellectis conducts expertise for CNES on Mars sample return.

Top

Press Releases 2000

08 Dec 2000
Cellectis grows and moves to the Biotop Pasteur incubator.
21 Sep 2000
Official press release from CELLECTIS and Pasteur Institute: CELLECTIS wins competition
20 Sep 2000
CELLECTIS SA is awarded a special prize as the first Biotech Company in nationwide competition.

Top

Last update :  02/05/2010